0001179110-22-001832.txt : 20220301
0001179110-22-001832.hdr.sgml : 20220301
20220301180844
ACCESSION NUMBER: 0001179110-22-001832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220225
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stewart Jeffrey Ryan
CENTRAL INDEX KEY: 0001761675
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 22700225
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2022-02-25
0
0001551152
AbbVie Inc.
ABBV
0001761675
Stewart Jeffrey Ryan
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
EVP, Chief Commercial Officer
Common Stock, $0.01 par value
2022-02-25
4
F
0
17093
149.54
D
82429
D
Common Stock, $0.01 par value
2022-03-01
4
S
0
6229
147.4276
D
76200
D
Common Stock, $0.01 par value
2022-03-01
4
S
0
12659
148.4935
D
63541
D
Common Stock, $0.01 par value
2022-03-01
4
S
0
2600
149.0357
D
60941
D
Common Stock, $0.01 par value
1338
I
By spouse in trust
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.86 to $147.85 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.86 to $148.85 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.48 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reporting person disclaims beneficial ownership of all securities held by his spouse.
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Jeffrey R. Stewart
2022-03-01